ADARx Pharmaceuticals, Inc.
NASDAQ:ADRXBiotechnology
Healthcare
$12.82 +0.73%
+$0.13 today
- Market cap
- $1.42B
- Beta
- 0.00
52W Low $16.64High $23.21
Volume 0.65M
Average 1.06M
ADRX Total Current Liabilities
All obligations due within one year.
No reported Total Current Liabilities figures are available to summarize.
Total Current Liabilities history
Currency unavailable · from the balance sheet
No Total Current Liabilities data reported for this period type.
Total Current Liabilities vs competitors
How ADRX compares with its peers on the latest reported figures
ADRX Competitors
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $176.13M USD | +236.3% | +14.3% | 72.0% | |
| Mar 2026 | $49.83M USD | -43.0% | +10.0% | 8.5% | |
| Mar 2026 | $40.81M USD | -8.7% | +22.6% | 9.2% | |
| Mar 2026 | $36.29M USD | +5.8% | +11.9% | 12.3% | |
| Mar 2026 | €35.09M EUR | -3.6% | +15.6% | 35.4% | |
| Mar 2026 | $34.37M USD | -30.4% | -34.1% | 14.0% | |
| Mar 2026 | $21.91M USD | — | — | 7.5% | |
| Mar 2026 | $10.46M USD | -45.7% | -14.7% | 9.1% | |
| Mar 2026 | $3.27M USD | -53.4% | -10.7% | 1.8% | |
ADRXADARx Pharmaceuticals, Inc. | — | — | — | — | — |
| Peer median (excluding ADRX) | — | -19.6% | +10.9% | 9.2% | |
Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Currency unavailable
ADARx Pharmaceuticals, Inc.
NASDAQ:ADRX
Intrinsic Alpha fair value
Locked
Current Price
$12.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.